MX2022014889A - Polioles de alquílo mononitrosilados y bisnitrosilados para su uso terapéutico. - Google Patents

Polioles de alquílo mononitrosilados y bisnitrosilados para su uso terapéutico.

Info

Publication number
MX2022014889A
MX2022014889A MX2022014889A MX2022014889A MX2022014889A MX 2022014889 A MX2022014889 A MX 2022014889A MX 2022014889 A MX2022014889 A MX 2022014889A MX 2022014889 A MX2022014889 A MX 2022014889A MX 2022014889 A MX2022014889 A MX 2022014889A
Authority
MX
Mexico
Prior art keywords
nitrosylated
mono
bis
therapeutic use
alkyl polyols
Prior art date
Application number
MX2022014889A
Other languages
English (en)
Inventor
Agvald Per Håkan
Leif Christofer Adding
Kristofer Bo Ingemar Nilsson
Original Assignee
Attgeno Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Attgeno Ab filed Critical Attgeno Ab
Publication of MX2022014889A publication Critical patent/MX2022014889A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invención se refiere al uso de propanodioles mononitrosilados y bisnitrosilados, y composiciones y formulaciones que comprenden estos, en métodos para el tratamiento de una infección microbiana.
MX2022014889A 2020-05-27 2021-05-27 Polioles de alquílo mononitrosilados y bisnitrosilados para su uso terapéutico. MX2022014889A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB2007928.1A GB202007928D0 (en) 2020-05-27 2020-05-27 New uses and methods
PCT/EP2021/064262 WO2021239906A1 (en) 2020-05-27 2021-05-27 Mono- and bis-nitrosylated alkyl polyols for therapeutic use

Publications (1)

Publication Number Publication Date
MX2022014889A true MX2022014889A (es) 2023-02-22

Family

ID=71406297

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022014889A MX2022014889A (es) 2020-05-27 2021-05-27 Polioles de alquílo mononitrosilados y bisnitrosilados para su uso terapéutico.

Country Status (12)

Country Link
US (1) US20230225984A1 (es)
EP (1) EP4157235A1 (es)
JP (1) JP2023527053A (es)
KR (1) KR20230035255A (es)
CN (1) CN115867263A (es)
AU (1) AU2021281044A1 (es)
BR (1) BR112022024054A2 (es)
CA (1) CA3184779A1 (es)
GB (1) GB202007928D0 (es)
IL (1) IL298588A (es)
MX (1) MX2022014889A (es)
WO (1) WO2021239906A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202007929D0 (en) * 2020-05-27 2020-07-08 Attgeno Ab New medical uses
GB202306258D0 (en) 2023-04-27 2023-06-14 Attgeno Ab New medical uses

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646181A (en) * 1992-07-02 1997-07-08 Research Foundation Of State University Of New York Method and compositions for treating impotence
EP1660059A1 (en) * 2003-06-06 2006-05-31 Johann Wolfgang Goethe University Glycyrrhizin or derivatives thereof for treating or preventing severe acute respiratory syndrome (sars)
US20050108047A1 (en) * 2003-11-19 2005-05-19 Vvii Newco 2003, Inc. Business methods for commercializing antibiotics
JP5191477B2 (ja) * 2006-03-14 2013-05-08 ラーシュ・エー・グスタフソン 治療用化合物および組成物の新規製造方法、それによって製造される化合物および組成物、並びにその使用
US20150132345A1 (en) * 2011-05-09 2015-05-14 Yossef Av-Gay Nitric oxide-sequestering topical formulations
WO2013132497A1 (en) * 2012-03-07 2013-09-12 Advanced Inhilation Therapies (Ait) Ltd. Inhalation of nitric oxide for treating respiratory diseases
US20140271731A1 (en) * 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US20180112200A1 (en) * 2014-12-22 2018-04-26 The Regents Of The University Of California Compositions and methods for generating antigens, antibodies, and immunotherapeutic compositions and methods
US12496377B2 (en) * 2016-12-16 2025-12-16 University Of Georgia Research Foundation, Inc. Nitric oxide releasing slippery surfaces for decreased fouling, thrombosis, and infection of medical devices
CA3048785A1 (en) * 2017-01-03 2018-07-12 The University Of North Carolina At Chapel Hill Nitric oxide-releasing alginates as biodegradable antibacterial scaffolds and methods pertaining thereto
WO2019173539A1 (en) * 2018-03-06 2019-09-12 The University Of North Carolina At Chapel Hill Nitric oxide-releasing cyclodextrins as biodegradable antibacterial scaffolds and methods pertaining thereto

Also Published As

Publication number Publication date
JP2023527053A (ja) 2023-06-26
GB202007928D0 (en) 2020-07-08
CN115867263A (zh) 2023-03-28
KR20230035255A (ko) 2023-03-13
CA3184779A1 (en) 2021-12-02
WO2021239906A1 (en) 2021-12-02
AU2021281044A1 (en) 2023-02-02
BR112022024054A2 (pt) 2023-02-14
US20230225984A1 (en) 2023-07-20
EP4157235A1 (en) 2023-04-05
IL298588A (en) 2023-01-01

Similar Documents

Publication Publication Date Title
PH12021550931A1 (en) New anthelmintic compounds
ZA202201364B (en) Deuterated compounds for use in the treatment of cancer
ZA202100855B (en) Personal care compositions
MX2013003634A (es) Derivados policiclicos heterociclicos y metodos de uso de los mismos para el tratamiento de enfermedades virales.
NZ593111A (en) Antibacterial compounds
TW200738242A (en) Dihydropteridinones in the treatment of respiratory diseases
PH12020500134A1 (en) Dihydrooxadiazinones
MX389965B (es) Compuestos de pirrolopiridina-anilina para el tratamiento de trastornos dermicos
PH12022550124A1 (en) Enzyme inhibitors
DE60332101D1 (de) Antimikrobielle zusammensetzung
MX2025010357A (es) Degradador de irak4, y uso del mismo
MY202884A (en) Compounds useful in hiv therapy
MX2019013562A (es) Compuestos de anilina heteroaromatica o fusionados para el tratamiento de trastornos dermicos.
PH12022550118A1 (en) Enzyme inhibitors
MX2019006768A (es) Peptidos antimicrobianos.
MX2022002069A (es) Inhibidores de enzimas.
MX2023010941A (es) Compuestos antibacterianos.
MX2023004955A (es) Compuestos de aminotiazol deuterados como compuestos antiviricos.
MX2024015077A (es) Benzopirimidina-4(3h)-onas como inhibidores de pi3k
MX2022011646A (es) Celulas t v delta1+ para el tratamiento de neoplasias mieloides.
MX2023010948A (es) Compuestos antibacterianos.
MX2023009677A (es) Inhibidores de enzimas.
PH12023550007A1 (en) Use of a phosphodiesterase 10 inhibitor for the treatment of tourette syndrome
JOP20230275A1 (ar) معدلات trex1
BR112022024054A2 (pt) Alquil polióis mono e bis-nitrolasilados para uso terapêutico